Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00002207

Public ClinicalTrials.gov record NCT00002207. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 7:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study of the Antiviral Activity of Once-Daily and Twice-Daily Dosing of Didanosine in Combination With Twice-Daily Dosing of Stavudine in HIV-Infected Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.

Study identification

NCT ID
NCT00002207
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2004
Primary completion
Jan 31, 2004
Completion
Jan 31, 2004
Last update posted
Apr 24, 2011

2004

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Clinsites / Sorra Research Ctr Birmingham Alabama 35203
Shared Med Research Foundation Tarzana California 91356
Indiana Univ School of Medicine / Dept of Infect Dis Indianapolis Indiana 46202
Medicine Faculty Associates Ypsilanti Michigan 48197
New Jersey Community Research Initiative Newark New Jersey 07103
ID Care Inc Somerville New Jersey 08876
Fanno Creek Clinic Portland Oregon 97219
Anderson Clinical Research Pittsburgh Pennsylvania 15213
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 75235
Univ of Texas Med Branch Galveston Texas 775550835
Houston Clinical Research Network Houston Texas 77006
Hampton Roads Med Specialists Hampton Virginia 23666
Dr Iraj Mirshahi Richmond Virginia 23220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002207, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2011 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002207 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →